Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-26 @ 2:58 AM
Study NCT ID:
NCT00970502
Status:
COMPLETED
Last Update Posted:
2017-04-10
First Post:
2009-09-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Sponsor:
Johnny Kao
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-01
First Submit QC Date:
None
Study First Post Date:
2009-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-23
Results First Submit QC Date:
None
Results First Post Date:
2017-04-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-24
Last Update Post Date:
2017-04-10
Last Update Post Date Type:
ACTUAL